|
|
Role of NFxB/HIF2a axis in renal cell carcinoma progression
|
5K08CA178168-03
|
$175,163
|
$175,163
|
ABEL, E
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Exploiting mTORC1-driven cancer cell vulnerabilities
|
5F32CA177108-02
|
$57,962
|
$57,962
|
ACKERMAN, DANIEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S1
|
|
$0
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S2
|
$64,741
|
$3,884
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S3
|
$229,232
|
$13,754
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S4
|
$593,811
|
$35,629
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S5
|
$917,771
|
$55,066
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S6
|
$68,356
|
$4,101
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S7
|
$778,576
|
$46,715
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S8
|
$73,651
|
$4,419
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-02
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-02
|
$24,080,302
|
$1,444,818
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-02
|
$737,200
|
$22,116
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$871,993
|
$43,600
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
5U10CA180790-02
|
$1,295,864
|
$38,876
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
|
NCTN Deep South Research Consortium
|
3U10CA180855-02S1
|
$199,999
|
$5,000
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-02
|
$497,800
|
$12,445
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$768,848
|
$38,442
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
$27,886
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
PHOTOACOUSTIC MICROSCOPY OF NEOVASCULARIZATION IN RENAL CANCER GROWTH AND THERAPY
|
5R01CA159959-05
|
$588,368
|
$588,368
|
ARBEIT, JEFFREY
|
WASHINGTON UNIVERSITY
|
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-21
|
$4,271,782
|
$427,178
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer
|
5R01CA168621-02
|
$370,388
|
$370,388
|
BALACHANDRAN, SIDDHARTH
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$113,744
|
$28,436
|
Bates, Susan
|
CCR (NCI)
|
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$170,616
|
$34,123
|
Bates, Susan
|
CCR (NCI)
|
|
|
Cancer Center Support Grant
|
3P30CA006516-50S1
|
$122,500
|
$2,450
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
3P30CA006516-50S2
|
$50,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
3P30CA006516-50S3
|
$125,000
|
$2,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
3P30CA006516-50S4
|
$200,000
|
$4,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
3P30CA006516-50S5
|
$62,500
|
$1,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
5P30CA006516-50
|
$11,162,542
|
$223,251
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-02
|
$528,806
|
$26,440
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-29S2
|
$334,740
|
$13,390
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S1
|
$34,176
|
$684
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S2
|
$810,357
|
$16,207
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-02
|
$9,967,453
|
$199,349
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$189,189
|
$47,297
|
Beutler, John
|
CCR (NCI)
|
|
|
Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
|
1R01CA196996-01
|
$398,025
|
$398,025
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
JHU ICMIC Program
|
5P50CA103175-10
|
$1,485,716
|
$29,714
|
BHUJWALLA, ZAVER
|
JOHNS HOPKINS UNIVERSITY
|
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-02S2
|
$34,899
|
$698
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-02
|
$10,609,226
|
$212,185
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$104,794
|
$104,794
|
Bottaro, Donald
|
CCR (NCI)
|
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$78,595
|
$7,860
|
Bottaro, Donald
|
CCR (NCI)
|
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$340,579
|
$85,145
|
Bottaro, Donald
|
CCR (NCI)
|
|
|
1/2 Addressing Rural Cancer Health Disparities: An SCC-SIUSM Partnership
|
1P20CA192987-01A1
|
$224,852
|
$224,852
|
BRARD, LAURENT
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
|
Kidney Cancer GWAS
|
ZIA CP010187 - 10460
|
$72,041
|
$72,041
|
Brown, Kevin
|
DCEG (NCI)
|
|
|
Laboratory of Translational Genomics_Brown
|
ZIA CP010201 - 10570
|
$342,438
|
$34,244
|
Brown, Kevin
|
DCEG (NCI)
|
|
|
NCI NCTN-Network Lead Academic Site at UPCI
|
5U10CA180844-02
|
$898,445
|
$22,461
|
BRUFSKY, ADAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
|
5R01CA175754-02
|
$329,925
|
$329,925
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-02
|
$1,171,980
|
$43,949
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
|
Families at high risk of cancer
|
ZIA CP004410 - 08285
|
$1,104,439
|
$55,222
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Total relevant funding to Kidney Cancer for this search: $39,115,446
|
